Research on Bone Fracture Risk with Dipeptidyl peptidase-4 inhibitors in Patients with Diabetes Mellitus

Research on Bone Fracture Risk with Dipeptidyl peptidase-4 inhibitors in Patients with Diabetes Mellitus

碩士 === 中國醫藥大學 === 醫務管理學系碩士班 === 105

Bibliographic Details
Main Authors:	Yu-Ting Sung, 宋鈺婷
Other Authors:	黃光華
Format:	Others
Language:	zh-TW
Published:	2017
Online Access:	http://ndltd.ncl.edu.tw/handle/56b839

Similar Items

The Effects of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Disease Risks in Type 2 Diabetes Mellitus
by: Pegah Yousefzadeh, et al.
Published: (2013-01-01)

DIPEPTIDYL PEPTIDASE 4 (DPP-4) INHIBITORS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS
by: Erna Kristin
Published: (2016-12-01)

Comparative effect of dipeptidyl-peptidase 4 inhibitors on laboratory parameters in patients with diabetes mellitus
by: Yayoi Nishida, et al.
Published: (2020-04-01)

Renoprotective Effect of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus
by: Hiroki Esaki, et al.
Published: (2017-11-01)

Incident cancer risk in dipeptidyl peptidase-4 inhibitor-treated patients with type 2 diabetes mellitus
by: Choi YJ, et al.
Published: (2019-08-01)

The role of dipeptidyl peptidase - 4 inhibitors in diabetic kidney disease
by: Usha ePanchapakesan, et al.
Published: (2015-08-01)

Emerging Roles of Dipeptidyl Peptidase-4 Inhibitors in Delaying the Progression of Type 1 Diabetes Mellitus
by: Gurgel Penaforte-Saboia J, et al.
Published: (2021-02-01)

Effect of dipeptidyl peptidase-4 inhibitors on fat metabolism in patients with type 2 diabetes mellitus
by: A S Ametov, et al.
Published: (2014-08-01)

Predictors of the Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Taiwanese Patients with Type 2 Diabetes Mellitus
by: Lin YH, et al.
Published: (2019-12-01)

Predictive Factors for Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus
by: Shusuke Yagi, et al.
Published: (2015-08-01)

Acute pancreatitis in patients with type 2 diabetes mellitus treated with dipeptidyl peptidase-4 inhibitors
by: Tzu-Lin Yang, et al.
Published: (2016-04-01)

Association between dipeptidyl peptidase-4 inhibitors use and leptin in type 2 diabetes mellitus
by: Xin Wei, et al.
Published: (2021-08-01)

Dipeptidyl-Peptidase IV inhibitors and glycemic control in type 2 Diabetes Mellitus
by: Lokendra Bahadur Sapkota, et al.
Published: (2016-03-01)

Research on Hypoglycemia Risk in Combination Therapy with Dipeptidyl Peptidase-4 Inhibitors and Other Oral Antidiabetes Medications in Patients with Diabetes Mellitus
by: Yu-Chieh Cheng, et al.
Published: (2014)

The effects of dipeptidyl peptidase-4 inhibitors on bone fracture among patients with type 2 diabetes mellitus: A network meta-analysis of randomized controlled trials.
by: Jun Yang, et al.
Published: (2017-01-01)

Nonglycemic effects of dipeptidyl peptidase-4 inhibitors
by: A S Ametov, et al.
Published: (2013-01-01)

The Nonglycemic Actions of Dipeptidyl Peptidase-4 Inhibitors
by: Na-Hyung Kim, et al.
Published: (2014-01-01)

The Effect of Dipeptidyl Peptidase-4 Inhibitors on Macrovascular and Microvascular Complications of Diabetes Mellitus: A Systematic Review
by: Olesya M. Taylor, PharmD, BCPS, et al.
Published: (2020-01-01)

Candidate Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes
by: Yun-Mi Jang, et al.
Published: (2011-04-01)

Effect of Dipeptidyl Peptidase-4 Inhibitors on Bone Metabolism and the Possible Underlying Mechanisms
by: Yinqiu Yang, et al.
Published: (2017-07-01)

Dipeptidyl Peptidase 4: A New Link between Diabetes Mellitus and Atherosclerosis?
by: Wellington Santana da Silva Júnior, et al.
Published: (2015-01-01)

Dipeptidyl peptidase 4 inhibitors in modern domestic practice
by: A. S. Ametov, et al.
Published: (2020-05-01)

Dipeptidyl peptidase-4 inhibitors use in clinical practice
by: Tatiana B. Morgunova, et al.
Published: (2019-04-01)

Navigating the chemical space of dipeptidyl peptidase-4 inhibitors
by: Shoombuatong W, et al.
Published: (2015-08-01)

Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid
by: Kaisa Tasanen, et al.
Published: (2019-06-01)

Dipeptidyl peptidase-4 inhibitors: Novel mechanism of actions
by: Awadhesh Kumar Singh
Published: (2014-01-01)

Health economic evaluation of dipeptidyl peptidase-4 inhibitors
by: Vishvas Garg
Published: (2011-01-01)

The Expression and Role of Dipeptidyl- Peptidase-4 (DPP-4) in Insulin Resistance and Diabetes Mellitus
by: Stevenson, Claire Louise
Published: (2014)

Dipeptidyl Peptidase-4 Inhibitors and the Risk of Pancreatitis in Patients with Type 2 Diabetes Mellitus: A Population-Based Cohort Study
by: Young-Gun Kim, et al.
Published: (2018-01-01)

Effect of Dipeptidyl-Peptidase 4 Inhibitors on Circulating Oxidative Stress Biomarkers in Patients with Type 2 Diabetes Mellitus
by: Elisabetta Bigagli, et al.
Published: (2020-03-01)

Inadequate Triglyceride Management Worsens the Durability of Dipeptidyl Peptidase-4 Inhibitor in Subjects with Type 2 Diabetes Mellitus
by: Masashi Shimoda, et al.
Published: (2017-01-01)

Combination treatment for type 2 diabetes mellitus (T2DM) : dipeptidyl peptidase-4 inhibitors (DPP-4) and metformin
by: Erna Kristin
Published: (2017-10-01)

Emerging role of dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes
by: Bernd Richter, et al.
Published: (2008-08-01)

Risk of Cardiovascular Events and Medical Cost of Dapagliflozin and Dipeptidyl Peptidase-4 Inhibitors
by: Jong-Mi Seong, et al.
Published: (2021-09-01)

Factors determining the clinical significance of dipeptidyl peptidase-4 inhibitors in the treatment of elderly patients with type 2 diabetes mellitus
by: I. V. Glinkina, et al.
Published: (2021-05-01)

Effect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes Mellitus
by: Han E, et al.
Published: (2020-11-01)

Treatment with metformin and a dipeptidyl peptidase-4 inhibitor elevates apelin levels in patients with type 2 diabetes mellitus
by: Fan YJ, et al.
Published: (2015-08-01)

Association between Dipeptidyl Peptidase-4 Inhibitor Prescription and Erythropoiesis-Stimulating Agent Hyporesponsiveness in Hemodialysis Patients with Diabetes Mellitus
by: Takeshi Hasegawa, et al.
Published: (2021-04-01)

Roles and Mechanisms of Dipeptidyl Peptidase 4 Inhibitors in Vascular Aging
by: Fen Cao, et al.
Published: (2021-08-01)

Association between Add-On Dipeptidyl Peptidase-4 Inhibitor Therapy and Diabetic Retinopathy Progression
by: Eugene Yu-Chuan Kang, et al.
Published: (2021-06-01)

Cannot write session to /tmp/vufind_sessions/sess_60elo98c7v21j2stauukvf6jg8